http://ift.tt/eA8V8J
HUDDINGE, Sweden, April 28, 2017 Significant events during the first quarter
The osteoarthritis trial evaluating MIV-711 received the go-ahead to continue without any modifications after a positive fourth review of safety data.
Christine Lind has been appointed as…
April 28, 2017 at 12:47PM
from
No comments:
Post a Comment